Related Experiment Videos

Preoperative oral antiemetics for reducing postoperative vomiting after tonsillectomy in children: granisetron versus

Y Fujii1, Y Saitoh, H Tanaka

  • 1Department of Anesthesiology, University of Tsukuba Institute of Clinical Medicine, Tsukuba City, Ibaraki, Japan.

Insights

Granisetron is more effective than perphenazine for preventing postoperative vomiting in children undergoing tonsillectomy. This randomized trial found superior complete response rates with granisetron, with no serious adverse events reported.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Surgical Outcomes

Background:

  • Postoperative vomiting is a common complication in pediatric tonsillectomy.
  • Effective antiemetic strategies are crucial for improving patient recovery and satisfaction.

Purpose of the Study:

  • To compare the efficacy of oral granisetron versus perphenazine in preventing postoperative vomiting in children undergoing tonsillectomy with or without adenoidectomy.
  • To evaluate the safety profile of both antiemetics in this pediatric population.

Main Methods:

  • A prospective, randomized, double-blinded trial involving 100 pediatric patients (ASA physical status I, aged 4-10 years).
  • Patients received either granisetron (40 microg/kg) or perphenazine (70 microg/kg) orally one hour before surgery.
  • Standard general anesthetic techniques were employed.

Main Results:

  • Granisetron demonstrated a significantly higher rate of complete response (no emesis, no rescue medication) compared to perphenazine.
  • Complete response rates at 0-3 hours post-anesthesia were 86% for granisetron vs. 60% for perphenazine (P < 0.05).
  • Complete response rates at 3-24 hours post-anesthesia were 86% for granisetron vs. 62% for perphenazine (P < 0.05).

Conclusions:

  • Preoperative oral granisetron is a more effective antiemetic than perphenazine for preventing postoperative vomiting in children undergoing tonsillectomy/adenoidectomy.
  • Both medications were well-tolerated, with no serious adverse events observed.
  • Granisetron offers a superior option for managing postoperative nausea and vomiting in this surgical context.
Abstract

Related Concept Videos